Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 3Phase 1/2 2Phase NA 1Phase EARLY_PHASE1 1Phase 4 1Phase 3 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 538Neoplasms 393Prostatic Neoplasms 261Colorectal Neoplasms 252Lung Neoplasms 202Carcinoma, Hepatocellular 177Stomach Neoplasms 162Pancreatic Neoplasms 151Rectal Neoplasms 143Motor Activity 128Colonic Neoplasms 126Carcinoma, Non-Small-Cell Lung 118Uterine Cervical Neoplasms 113Polycystic Ovary Syndrome 96Head and Neck Neoplasms 96Esophageal Neoplasms 92Neoplasm Metastasis 71Brain Neoplasms 68Liver Neoplasms 67Ovarian Neoplasms 65Recurrence 60Urinary Bladder Neoplasms 59Pain 55Fatigue 54Lymphoma 53Endometrial Neoplasms 52Anxiety Disorders 50Melanoma 48Thyroid Neoplasms 47Pain, Postoperative 41

Interventions

pegylated granulocyte colony-stimulating factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Unknown × Advanced Pancreatic Cancer × Clear all
NCT04239001 2020-01-23

Efficacy and Safety of Pegylated Recombinant Human Granulocyte Stimulating Factor in Secondary Prevention of Albumin Paclitaxel Combined With S-1 in the First-line Treatment of Advanced Pancreatic Cancer

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Phase NA Unknown
20 enrolled
Gastrointestinal

Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡